These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11306172)
1. In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy. Messier N; Laflamme L; Hamann G; Langlois MF Mol Cell Endocrinol; 2001 Mar; 174(1-2):59-69. PubMed ID: 11306172 [TBL] [Abstract][Full Text] [Related]
2. Triac regulation of transcription is T(3) receptor isoform- and response element-specific. Messier N; Langlois MF Mol Cell Endocrinol; 2000 Jul; 165(1-2):57-66. PubMed ID: 10940484 [TBL] [Abstract][Full Text] [Related]
3. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. Takeda T; Suzuki S; Liu RT; DeGroot LJ J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251 [TBL] [Abstract][Full Text] [Related]
4. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function. Wan W; Farboud B; Privalsky ML Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373 [TBL] [Abstract][Full Text] [Related]
5. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity. Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558 [TBL] [Abstract][Full Text] [Related]
6. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone. Ng L; Forrest D; Haugen BR; Wood WM; Curran T Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112 [TBL] [Abstract][Full Text] [Related]
7. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone. Tagami T; Jameson JL Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636 [TBL] [Abstract][Full Text] [Related]
9. The function of retinoid X receptors on negative thyroid hormone response elements. Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079 [TBL] [Abstract][Full Text] [Related]
10. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential. Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988 [TBL] [Abstract][Full Text] [Related]
11. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. Hayashi Y; Sunthornthepvarakul T; Refetoff S J Clin Invest; 1994 Aug; 94(2):607-15. PubMed ID: 8040316 [TBL] [Abstract][Full Text] [Related]
12. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629 [TBL] [Abstract][Full Text] [Related]
13. Functional properties of a mutant T3 receptor beta (R338W) identified in a subject with pituitary resistance to thyroid hormone. Sasaki S; Nakamura H; Tagami T; Miyoshi Y; Nakao K Mol Cell Endocrinol; 1995 Aug; 113(1):109-17. PubMed ID: 8674808 [TBL] [Abstract][Full Text] [Related]
14. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583 [TBL] [Abstract][Full Text] [Related]
16. A novel point mutation in cluster 3 of the thyroid hormone receptor beta gene (P247L) causing mild resistance to thyroid hormone. Pohlenz J; Manders L; Sadow PM; Kansal PC; Refetoff S; Weiss RE Thyroid; 1999 Dec; 9(12):1195-203. PubMed ID: 10646658 [TBL] [Abstract][Full Text] [Related]
17. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924 [TBL] [Abstract][Full Text] [Related]
18. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors. Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109 [TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Piedrafita FJ; Ortiz MA; Pfahl M Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031 [TBL] [Abstract][Full Text] [Related]
20. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. Torre P; Bertoli M; Di Giovanni S; Scommegna S; Conte C; Novelli G; Cianfarani S J Endocrinol Invest; 2005; 28(7):657-62. PubMed ID: 16218051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]